Neil Mitra is the founder and CEO of Mitra Biotechnologies, a startup that is creating novel patented rapid point-of-care diagnostics and predicting disease conditions.
Backed by Cory Levy, Pareto Holdings, Alchemist Accelerator, and Andrew Cote.
They are currently developing nanomaterial platforms to make blood tests 1000X cheaper, 10X faster, and 50X more accurate at the point-of-care.
Neil is also a Global Teen Leader, Presidential Scholar at UBC, Mason Foundation Member, and Z Fellow.
We spoke about
→ his early science projects
→ innovations in rapid diagnostics
→ the dark side of biotech exits
→ the future of preventative healthcare
→ AI’s impact
→ and the quest for digital biology.
Learn more about Neil and his company below:
linkedin.com/in/neilmitra
Cascade